Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials.

By C. Vale, J. Tierney, L. Stewart, M. Brady, K. Dinshaw, A. Jakobsen, Mahesh K B Parmar, G. Thomas, T. Trimble, D. Alberts and 16 more. Journal of Clinical Oncology, 2008

890 citations recorded by the source corpus.

Subfields: Cancer Research, Epidemiology, Obstetrics and Gynecology

View Paper: https://www.semanticscholar.org/paper/2413e4741d88cb2abbb56249c35b9dfc195f19e5

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

R. Pötter
A. Sturdza
C. Kirisits
K. Tanderup
D. Berger
C. Haie-meder
L. Tan
L. Fokdal

Citations in the corpus

Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study. (2016, background): “In a metaanalysis of individual patient data of 3128 patients treated in 13 randomised trials on chemo-radiotherapy + conventional BT [26], the crude PC rate was also 77% (2406/3128).”
Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer (2011, methodology): “Opposed to concomitant chemotherapy with local control improvement of 7% for IIB and 3% for III/IVA [19], the effect of image guided brachytherapy seems to be in fact most pronounced in very advanced disease (tumours >5 cm) with an absolute local control beneﬁt of 23–26% in the Vienna series.”